Oncologie proved you wrong. DEALS can be made in China and Europe, if not with USA BP. No dilution in those two, using our biomarkers only, never mind BB or Bavi.
The old crew had 10 plus years to do it and didn't get it done. The new crew would have much preferred a larger front end... doesn't sound like there was much of a bidding war does it? And the deal is not done yet... be careful cause sometimes folks will say it ain't worth the hassle.
If it's such a steal would not BP jump in before it's too late? ... Sorry but all our "astronomical" expectations come from someone that preferred cash over shares.. do the math on that one...
No more expenditures... $100 mil in milestones (prob some within the first year which could fund Avid expansion) vs $70 mil out for development and mid teen royalty rates...
Keep in mind the massive amount spent on bavi development was mostly wasted with min return with trial failure data...
Here's something to consider... how quickly fortunes can change in biotech..
News 
Market Data 
Discover 
